Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

107 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Accurate prostate cancer detection based on enrichment and characterization of prostate cancer specific circulating tumor cells.
Limaye S, Chowdhury S, Rohatgi N, Ranade A, Syed N, Riedemann J, Patil D, Akolkar D, Datta V, Patel S, Chougule R, Shejwalkar P, Bendale K, Apurwa S, Schuster S, John J, Srinivasan A, Datar R. Limaye S, et al. Among authors: rohatgi n. Cancer Med. 2023 Apr;12(8):9116-9127. doi: 10.1002/cam4.5649. Epub 2023 Jan 30. Cancer Med. 2023. PMID: 36718027 Free PMC article.
Practical Clinical Consensus Guidelines for the Management of Cancer Associated Anemia in Low- and Middle-Income Countries.
Parikh PM, Aggarwal S, Biswas G, Gulia S, Agarwala V, Basade M, Mohapatra PN, Vamshi KM, Warrier A, Prasad K, Roy P, Chandrakant MV, Malhotra H, Hingmire S, Paul D, Maniar V, Gupta A, Panda SS, Samar A, Rohatgi N, Dattatreya S, Krishnamurthy M, Thirumalairaj R. Parikh PM, et al. Among authors: rohatgi n. South Asian J Cancer. 2023 Sep 15;12(2):93-99. doi: 10.1055/s-0043-1771445. eCollection 2023 Apr. South Asian J Cancer. 2023. PMID: 37969669 Free PMC article.
Discordance in Recommendation Between Next-Generation Sequencing Test Reports and Molecular Tumor Boards in India.
Mathew A, Davis S, Boby JM, R I A, Suryavanshi M, Dawood SS, Panda PK, Nag SM, Das A, Rohatgi N, Popat S, Shah RNH, Thampy C, Parikh AR, Yadav S, Mehta P, Singh R, Mukherji D, Shilpakar R, Mullapally SK, Sirohi B. Mathew A, et al. Among authors: rohatgi n. JCO Glob Oncol. 2024 Mar;10:e2300330. doi: 10.1200/GO.23.00330. JCO Glob Oncol. 2024. PMID: 38484196 Free PMC article.
Adapted large language models can outperform medical experts in clinical text summarization.
Van Veen D, Van Uden C, Blankemeier L, Delbrouck JB, Aali A, Bluethgen C, Pareek A, Polacin M, Reis EP, Seehofnerová A, Rohatgi N, Hosamani P, Collins W, Ahuja N, Langlotz CP, Hom J, Gatidis S, Pauly J, Chaudhari AS. Van Veen D, et al. Among authors: rohatgi n. Nat Med. 2024 Apr;30(4):1134-1142. doi: 10.1038/s41591-024-02855-5. Epub 2024 Feb 27. Nat Med. 2024. PMID: 38413730
Sunitinib in Patients With Breast Cancer With FGFR1 or FGFR2 Amplifications or Mutations: Results From the Targeted Agent and Profiling Utilization Registry Study.
Calfa CJ, Rothe M, Mangat PK, Garrett-Mayer E, Ahn ER, Burness ML, Gogineni K, Rohatgi N, Al Baghdadi T, Conlin A, Gaba A, Hamid O, Krishnamurthy J, Gavini NJ, Gold PJ, Rodon J, Rueter J, Thota R, Grantham GN, Hinshaw DC, Gregory A, Halabi S, Schilsky RL. Calfa CJ, et al. Among authors: rohatgi n. JCO Precis Oncol. 2024 Feb;8:e2300513. doi: 10.1200/PO.23.00513. JCO Precis Oncol. 2024. PMID: 38354330
Nivolumab Plus Ipilimumab in Patients With Solid Tumors With ATM Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
Rohatgi N, Rothe M, Mangat PK, Garrett-Mayer E, Meric-Bernstam F, Pisick E, Alese OB, Reynolds CM, Thota R, Vaccaro GM, von Mehren M, Arend RC, Chiu VK, Duvivier HL, Gold PJ, Hack K, Marr AS, Winer A, Grantham GN, Hinshaw DC, Gregory A, Halabi S, Schilsky RL. Rohatgi N, et al. JCO Precis Oncol. 2023 Sep;7:e2300279. doi: 10.1200/PO.23.00279. JCO Precis Oncol. 2023. PMID: 38039429
107 results